Related Topics
     

    Sherr: News Releases & Feature Stories

     
    10/09/2013
    St. Jude Children’s Research Hospital scientist recognized by American-Italian Cancer Foundation

    Charles J. Sherr, M.D., Ph.D., to receive the Prize for Scientific Excellence in Medicine by the American-Italian Cancer Foundation.

     
     
    04/26/2013
    Charles Sherr, M.D., Ph.D., recognized as 2013 fellow of the American Academy of Arts and Sciences

    St. Jude Children’s Research Hospital scientist named to honorary society.

     
     
    03/27/2013
    St. Jude scientist named American Association for Cancer Research Academy Fellow

    Charles Sherr, M.D., Ph.D., of St. Jude Children’s Research Hospital, is honored by the AACR Academy for his scientific contributions to advancing understanding and treatment of cancer.

     
     
    12/18/2009
    St. Jude faculty member named American Association for the Advancement of Science (AAAS) 2009 Fellow

    Charles Sherr, MD, PhD, co-chair of Genetics and Tumor Cell Biology at St. Jude Children’s Research Hospital and a Howard Hughes Medical Institute Investigator, has been awarded the distinction of American Association for the Advancement of Science (AAAS) Fellow. AAAS is the world’s largest general scientific society.

     
     
    10/22/2007
    St. Jude discovers factors that accelerate Gleevec™ resistance

    St. Jude investigators provide strong evidence for why the targeted therapy drug imatinib (Gleevec™) is often unable to prevent relapse of a particularly aggressive form of acute lymphoblastic leukemia (ALL).

     
     
    03/19/2007
    A Knock Out for Leukemia

    St. Jude researchers prepare to knock out a rare form of leukemia.

     
     
    05/25/2006
    St. Jude unlocks mystery of very aggressive leukemia

    Loss of Arf gene in acute lymphoblastic leukemia makes some forms of this cancer resistant to treatment with imatinib; but blocking JAK kinases can restore the sensitivity of cells to this drug.

     
     
    11/08/2004
    Charles Sherr, MD, PhD, elected to Institute of Medicine

    Charles J. Sherr, M.D., Ph.D., of St. Jude Children's Research Hospital, has been elected to the Institute of Medicine (IOM), a prestigious branch of the National Academy of Sciences.

     
     
    03/07/2003
    St. Jude faculty member to receive prestigious award for cancer discoveries and research

    Charles Sherr, M.D., Ph.D., a member of the Genetics & Tumor Cell Biology Department at St. Jude and a Howard Hughes Medical Institute investigator, is one of two scientists world wide to receive the prestigious Landon-AACR Prize for Cancer Research.

     
     
    03/03/2003
    Evolution boosted anti-cancer prowess of a primordial gene by linking it to a more efficient set of genes

    Researchers discovered that the Arf gene was once moderately effective in slowing down cellular reproduction until it linked up with a more efficient set of genes to create a powerful anti-cancer response. Arf have evolved to slow the cell's metabolism and growth by limiting production of ribosomes, which guide production of all other cellular proteins.